[Federal Register Volume 66, Number 100 (Wednesday, May 23, 2001)]
[Notices]
[Page 28526]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-13070]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Vaccines and Related Biological Products Advisory Committee; 
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Vaccines and Related Biological Products 
Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on June 11, 2001, 11:30 
a.m. to 2:30 p.m.
    Location: Food and Drug Administration, 8800 Wisconsin Ave., Bldg. 
29-B, conference room 1NN06, Bethesda, MD. This meeting will be held 
via telephone conference call. A speaker phone will be provided in the 
conference room to allow public participation in the meeting.
    Contact: Nancy T. Cherry or Denise H. Royster, Center for Biologics 
Evaluation and Research (HFM-71), Food and Drug Administration, 1401 
Rockville Pike, Rockville, MD 20852, 301-827-0314, or FDA Advisory 
Committee Information Line, 1-800-741-8138, (301-443-0572 in the 
Washington, DC area), code 12391. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: The committee will discuss the intramural scientific 
research program of the Laboratory of Pediatric and Respiratory Viral 
Diseases.
    Procedure: On June 11, 2001, from 11:30 a.m. to 1:30 p.m., the 
meeting is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the committee. Written submissions may be made to the contact person by 
May 31, 2001. Oral presentations from the public will be scheduled 
between approximately 12:20 p.m. and 1:25 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before May 31, 2001, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Closed Committee Deliberations: On June 11, 2001, from 1:30 p.m. to 
2:30 p.m., the meeting will be closed to permit discussion where 
disclosure would constitute a clearly unwarranted invasion of personal 
privacy (5 U.S.C. 552b(c)(6)). The meeting will be closed to discuss 
personal information concerning individuals associated with the 
research program.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: May 17, 2001.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 01-13070 Filed 5-22-01; 8:45 am]
BILLING CODE 4160-01-S